CClinicalTrials.gg
CompletedNCT03029754Updated Jan 9, 2019

Effect of Passive Leg Raise for Pediatric Peripheral IV Placement

An interventional study of Passive leg raise in Intravenous Access, sponsored by University of Saskatchewan. Completed at 1 site in Canada. Open to participants aged 3 Months to 14 Years. Per ClinicalTrials.gov, last updated 2019-01-09.

Sponsored by University of Saskatchewan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
87
Allocation
Randomized
Ages
3 Months to 14 Years
Sex
All
01

Study summary

The investigators wish to determine whether passive leg raise allows for easier peripheral vascular access in the pediatric population. The investigators hypothesize that pediatric anesthesiologists will have higher rates of successful intravenous catheterization in children where a passive leg raise is employed.

02

Conditions studied

  • Intravenous Access
03

In context

Lead sponsor

University of Saskatchewan is the lead sponsor of 237 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • pediatric participants undergoing dental procedures under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • Children who already have adequate IV access
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
87 participants (actual)

Study arms

  • Experimental
    Passive leg raise

    Participant's legs will be raised with a bolster prior to IV insertion.

    Procedure: Passive leg raise

  • No intervention
    No leg raise

    Participants will lie flat prior to IV insertion.

Interventions

  • ProcedurePassive leg raise

    A baseline vein diameter will be obtained using ultrasound by the sub-investigator. Then a nurse will raise the child's legs using a bolster while a second measurement of the child's vein diameter is recorded by the sub-investigator. The anesthesiologist will then place the IV and rate the degree of difficulty encountered.

06

What researchers measure

Primary outcomes

  1. Mean change in peripheral vein diameter

    Change between vein diameter at baseline and following group allocation.

    Time frame: at 5 minutes

07

Study locations

1 site
  • Royal University Hospital
    Saskatoon, Saskatchewan S7N 0W8, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03029754
Lead sponsor
University of Saskatchewan
Responsible party
Jonathan Gamble (M.D., University of Saskatchewan) — Principal investigator
First posted
Jan 24, 2017
Start date
May 17, 2017
Primary completion
Dec 14, 2017
Completion
Dec 14, 2017
Last update
Jan 9, 2019

Study contacts

Jonathan Gamble, MD
principal investigator · University of Saskatchewan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion